DIVISLAB — Divi's Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹974.72bn
- IN₹938.61bn
- IN₹77.68bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49,463 | 53,944 | 69,694 | 89,598 | 77,675 |
Cost of Revenue | |||||
Gross Profit | 27,858 | 29,205 | 42,186 | 54,706 | 40,787 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 32,408 | 37,542 | 43,547 | 53,874 | 57,417 |
Operating Profit | 17,055 | 16,402 | 26,147 | 35,725 | 20,258 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18,551 | 18,195 | 26,660 | 36,835 | 23,686 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13,527 | 13,765 | 19,843 | 29,605 | 18,234 |
Net Income Before Extraordinary Items | |||||
Net Income | 13,527 | 13,765 | 19,843 | 29,605 | 18,234 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13,527 | 13,765 | 19,843 | 29,605 | 18,234 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 51 | 51.9 | 74.9 | 112 | 68.7 |
Dividends per Share |